Get started
Author

Joseph Estabrook

Observed names: Estabrook, Joseph, Estabrook, Joseph, 1793-1855, Joseph Estabrook (15321286)
ORCID: 0000-0002-1027-3315
Observed ORCID: 0000-0002-1027-3315
OpenAlex ID: A5069454150
An expanded universe of cancer targets
2021 · William C. Hahn, Joel S. Bader, et al. · Cell · 214
PDF
Transcriptome alterations in myotonic dystrophy skeletal muscle and heart
2018 · Eric T Wang, Daniel Treacy, et al. · Human Molecular Genetics · 128
PDF
An omic and multidimensional spatial atlas from serial biopsies of an evolving metastatic breast cancer
2022 · Brett E. Johnson, Allison L. Creason, et al. · Cell Reports Medicine · 61
PDF
Antisense transcription of the myotonic dystrophy locus yields low-abundant RNAs with and without (CAG)n repeat
2017 · Anke E. E. G. Gudde, Simon J. van Heeringen, et al. · RNA Biology · 38
PDF
Selective enrichment of plasma cell-free messenger RNA in cancer-associated extracellular vesicles
2023 · Hyun Ji Kim, Matthew J. Rames, et al. · Communications Biology · 29
PDF
Predicting transcription factor activity using prior biological information
2024 · William M. Yashar, Joseph Estabrook, et al. · iScience · 19
PDF
PU.1 and MYC transcriptional network defines synergistic drug responses to KIT and LSD1 inhibition in acute myeloid leukemia
2022 · Brittany M. Curtiss, Jake VanCampen, et al. · Leukemia · 17
PDF
Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia
2023 · William M. Yashar, Brittany M. Curtiss, et al. · Molecular Cancer Research · 12
PDF
Asxl1 deletion disrupts MYC and RNA polymerase II function in granulocyte progenitors
2022 · Theodore P. Braun, Joseph Estabrook, et al. · Leukemia · 12
PDF
An Omic and Multidimensional Spatial Atlas from Serial Biopsies of an Evolving Metastatic Breast Cancer
2020 · Brett E. Johnson, Allison L. Creason, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 6
PDF
Oncogenic SETBP1 Mutations Combine with Activating Mutations in CSF3R to Produce a Highly Proliferative, Lethal Leukemia through Aberrant Myc Signaling
2020 · Sarah A Carratt, Theodore P. Braun, et al. · Blood · 2
Chronic IL1β Exposure Enhances Self-Renewal Ability and Myeloid Priming in TET2 Deficient Stem and Progenitor Cells
2022 · John McClatchy, Ruslan Strongantsev, et al. · Blood · 1
Supplementary Fig. 11 from Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia
2025 · William M. Yashar, Brittany M. Curtiss, et al.
Supplementary Table 8 from Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia
2025 · William M. Yashar, Brittany M. Curtiss, et al.
Supplementary Fig. 1 from Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia
2025 · William M. Yashar, Brittany M. Curtiss, et al.
Supplementary Table 4 from Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia
2025 · William M. Yashar, Brittany M. Curtiss, et al.
Supplementary Table 16 from Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia
2025 · William M. Yashar, Brittany M. Curtiss, et al.
Supplementary Table 9 from Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia
2025 · William M. Yashar, Brittany M. Curtiss, et al.
Supplementary Table 11 from Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia
2025 · William M. Yashar, Brittany M. Curtiss, et al.
Supplementary Fig. 10 from Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia
2025 · William M. Yashar, Brittany M. Curtiss, et al.
Supplementary Table 12 from Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia
2025 · William M. Yashar, Brittany M. Curtiss, et al.
Supplementary Table 17 from Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia
2025 · William M. Yashar, Brittany M. Curtiss, et al.
Supplementary Table 6 from Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia
2025 · William M. Yashar, Brittany M. Curtiss, et al.
Supplementary Fig. 3 from Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia
2025 · William M. Yashar, Brittany M. Curtiss, et al.
Supplementary Table 14 from Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia
2025 · William M. Yashar, Brittany M. Curtiss, et al.
Works count: 196
Citation count: 539
H-index: 9
I10-index: 9
Year
Topic
Type